• Decrease font size
  • Default font           size
  • Increase font size
Key Contacts PDF Print E-mail
Friday, 19 December 2008 12:34

David Hipkiss - CEO

David is co-founder and CEO of Prosonix, and has 19 years experience in business development and international marketing of cutting edge technologies in high growth, complex, intellectual property-rich environments such as the pharmaceutical industry. Prior to setting up Prosonix in 2006 he held a number of senior positions with international responsibility in Accentus, Dow Chemicals, Ascot plc, ChiroTech, and Air Products and Chemicals Inc. David holds a Bachelors Degree in Chemical Engineering.

Andy Bush - COO / CFO

Andy is COO / CFO and co-founder of Prosonix and has over 25 years' experience of international business management. Prior to setting up Prosonix in 2006 he held senior positions in two AEA Technology businesses in change management and business transformation roles and  enjoyed a highly successful 18 year career in BOC spanning technical, operations and commercial management and was responsible for winning several long-term, multi-million pound business contracts. Andy holds a Bachelors Degree in Chemical Engineering and Masters Degree in Business Administration. Andy is also a Chartered Engineer.  

Ludovic Bonnet - Project Manager

Ludovic holds a Chemical Engineering Diploma followed by a PhD in Catalysis and Synthetic Chemistry. Ludovic previously worked with Bristol Myers Squibb and Evotec (now part of Aptuit) working in Process Development and Custom Preparation.

John Burns - Engineering Manager

John holds two degrees in Mathematics followed by a PhD in Chemical Engineering. He worked for eight years at Newcastle University developing equipment in the field of Process Intensification, then moved on to work for three years at Protensive Ltd. as Research and Development Manager. Whilst at Protensive, John was actively involved in the development of Spinning Disc Reactor technology.

Last Updated on Monday, 08 August 2011 12:41
 

Latest News

03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest

Events

Respiratory Drug Delivery 2012
10 October 2011 08:57
article thumbnai